Home » News » Awards & Advancement » Anavex appoints Robert Chisholm as CFO

Anavex appoints Robert Chisholm as CFO

Friday, June 29, 2012

Anavex Life Sciences, a pharmaceutical company based in Vancouver, has appointed Robert Chisholm as chief financial officer.

Chisholm will remain on the Anavex board of directors, on which he has served since May 2011.  A veteran finance and administration executive with more than 25 years of experience, Chisholm has significant expertise in corporate finance, strategic business initiatives and the unique requirements of growth-oriented public companies. He also serves as a director and audit committee member for a number of other public companies.

Chisholm also currently serves as CFO and a director of both Savary Capital and OMT, CFO and a partner of Emprise Capital, CFO of TMT Resources and Ripper Oil and Gas, and member of the board of Rare Earth Industries.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!